Relapsed or Refractory Peripheral T-cell Lymphoma

Explore clinical trials studying Relapsed or Refractory Peripheral T-cell Lymphoma. Study availability and eligibility vary by location and protocol.

3 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Relapsed or Refractory Peripheral T-cell Lymphoma trial results

Recruiting

NCT05833724

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations: Chang Gung Memorial Hospital, Kaohsiung Kaohsiung City, Taiwan

Kaohsiung Medical University Chung-Ho Memorial Hospital Kaohsiung City, Taiwan

Far eastern memorial hospital New Taipei City, Taiwan

Taichung Veterans General Hospital Taichung, Taiwan

Completed

NCT02464228

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +14 more
Locations: Stanford University Medical Center Palo Alto, California, United States

Yale University, Yale Cancer Center New Haven, Connecticut, United States

H. Lee Moffitt Cancer Center & Research Institute, Inc. Tampa, Florida, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View all 13 locations

Completed

NCT03356678

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations: Samsung Medical Center Seoul, Seoul, Korea, Republic of, South Korea

81, Irwon-ro, Gangnam-gu, Seoul, Republic of Korea Seoul, South Korea